RTX vs UNH: Which Is the Better Buy?
Side-by-side comparison of RTX Corporation and UnitedHealth Group Incorporated β fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
RTX Corporation Β· Industrials
$172.90
-21.3% upside to fair value
Grade D
VS
UnitedHealth Group Incorporated Β· Healthcare
$353.52
+97.1% upside to fair value
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+97.1%).
UNH trades at a lower forward P/E
(26.7x).
These are model outputs β not personalized investment advice.
See all research β
Valuation & Fundamentals
| Metric |
RTX |
UNH |
| Current Price |
$172.90 |
$353.52 |
| Fair Value Estimate |
$136.05 |
$696.88 |
| Upside to Fair Value |
-21.3%
|
+97.1%
|
| Market Cap |
$232.8B |
$320.9B |
| Forward P/E |
32.1x
|
26.7x
|
| EV / EBITDA |
19.2x
|
16.1x
|
| Price / Sales |
2.6x
|
0.7x
|
| Price / FCF |
27.9x
|
16.3x
|
| Revenue Growth YoY |
+8.7%
|
+2.0%
|
| Gross Margin |
20.2%
|
18.8%
|
| Operating Margin |
10.4%
|
4.2%
|
| Return on Equity |
11.2%
|
12.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.59%
|
6.13%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
RTX Corporation is a leading aerospace and defense company with a diversified portfolio spanning Pratt & Whitney jet engines, Collins Aerospace avionics, and Raytheon Intelligence & Space defense systems. The company benefits from a strong competitive moat supported by a $271 billion backlog and multi-year contracts, driving consistent revenue growth of 10% in 2025 and 9% in Q1 2026. Earnings groβ¦
UnitedHealth Group Incorporated operates as a leading healthcare company with two main platforms: UnitedHealthcare, providing health benefits coverage, and Optum, offering information and technology services. The company benefits from a durable competitive moat due to its scale, integrated platforms, and broad market reach serving over 170 million consumers. Despite strong revenue growth of 12% yβ¦
Accumulation Zones
| Metric |
RTX |
UNH |
| Zone Low |
$102.04 |
$522.66 |
| Zone High |
$115.64 |
$592.35 |
| In Buy Zone? |
No
|
Yes
|